Gyre Therapeutics (GYRE)
A majority-owned Beijing unit sells China's pirfenidone lung-fibrosis therapy while San Diego runs the antifibrotic pipeline.
$7.34
vs last close−0.15 (−2.00%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 7.94% | 8.85M shares | |
|---|---|---|---|
| 62 holders · as of Jun 30, 2026 | |||
| Insiders | 5.46% | 6.09M shares | |
| 4 holders · as of Jun 22, 2026 | |||
| Other | 86.60% | 96.57M shares | |
| remainder | |||
111.51M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
62 holders · 8.85M shares · 15 new positions · 45 increased · 9 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| SC China Holding Ltd | 3.75M | 3.36% | +3.75Mnew | Aug 13, 2026 |
| BlackRock, Inc. | 993.9K | 0.89% | +235.3K | Aug 7, 2026 |
| Octagon Capital Advisors LP | 954.4K | 0.86% | +954.4Knew | Aug 14, 2026 |
| Vanguard Capital Management LLC | 876.9K | 0.79% | −107.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 533.0K | 0.48% | +101.5K | Aug 12, 2026 |
| State Street Corp | 245.4K | 0.22% | +29.1K | Aug 7, 2026 |
| Charles Schwab Investment Management Inc | 184.3K | 0.17% | +19.0K | Aug 14, 2026 |
| Sixth Street Partners Management Company, L.P. | 184.3K | 0.17% | +184.3Knew | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| GNI USA, Inc.incl. GNI Group Ltd. | 69.10% | 86.32M | 13D | May 6, 2026 |
| Ping Lanincl. Ying Luo | 8.60% | 10.21M | 13D | May 6, 2026 |
| Songjiang Maincl. Yueying Zhu | 6.33% | 7.34M | 13D | May 7, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 18, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 3,000 | $6.35 | 700,000 |
| Jun 10, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale · 2 lots | 11,418 | $6.22 | 700,000 |
| Jun 9, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale · 2 lots | 17,500 | $6.14 | 700,000 |
| Jun 11, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 2,800 | $6.17 | 700,000 |
| Jun 4, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 19,575 | $6.13 | 700,000 |
| Jun 5, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 15,401 | $6.40 | 700,000 |
| May 26, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 4,000 | $6.10 | 700,000 |
| May 22, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 3,500 | $6.08 | 700,000 |
| May 21, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 12,820 | $6.15 | 700,000 |
| May 19, 2026 | Weiguo Yeofficer: Chief Operating Officer | Sale | 9,120 | $6.37 | 700,000 |
House and Senate disclosures
Not reported.